A six-minute case video on a patient still above her goals after losing weight on Wegovy. Novo Nordisk funded the production, so treat it as sponsored education.
Recap by typeshit. Full story at Medical Republic.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A short blog pointer noting that different GLP-1 medicines have different uses and suggesting people talk with a provider about which, if any, fits them.
A clinician-focused rundown of the FDA-approved oral GLP-1 that can be taken without fasting or water restrictions.
Loading…